Byetta litigation
Claims allege that Byetta, an earlier injectable diabetes drug in the same family as today’s GLP‑1 medications, was linked to pancreatitis and pancreatic cancer.
Free case review
What the claims allege
Byetta (exenatide) was among the first incretin-based diabetes drugs. Adverse event reports and studies raised concerns about inflammation of the pancreas and pancreatic cancer, and the litigation alleged the manufacturers failed to adequately warn prescribers of those risks.
Injuries named in the litigation
- Acute and chronic pancreatitis
- Pancreatic cancer
- Thyroid cancer
Who may qualify
If you used Byetta and were hospitalized with pancreatitis or diagnosed with pancreatic or thyroid cancer, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.